BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saleiro D, Platanias LC. Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints. Semin Immunol 2019;43:101299. [PMID: 31771762 DOI: 10.1016/j.smim.2019.101299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Azzarito G, Kurmann L, Leeners B, Dubey RK. Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence. Cells 2022;11:2967. [DOI: 10.3390/cells11192967] [Reference Citation Analysis]
2 Pujantell M, Altfeld M. Consequences of sex differences in Type I IFN responses for the regulation of antiviral immunity. Front Immunol 2022;13:986840. [DOI: 10.3389/fimmu.2022.986840] [Reference Citation Analysis]
3 Liao Z, Huang J, Lo PC, Lovell JF, Jin H, Yang K. Self-adjuvanting cancer nanovaccines. J Nanobiotechnology 2022;20:345. [PMID: 35883176 DOI: 10.1186/s12951-022-01545-z] [Reference Citation Analysis]
4 Perez RE, Saleiro D, Ilut L, Schiltz GE, Eckerdt F, Fish EN, Platanias LC. Regulation of IFNα-induced expression of the short ACE2 isoform by ULK1. Mol Immunol 2022;147:1-9. [PMID: 35489289 DOI: 10.1016/j.molimm.2022.04.008] [Reference Citation Analysis]
5 Saleiro D, Wen JQ, Kosciuczuk EM, Eckerdt F, Beauchamp EM, Oku CV, Blyth GT, Fischietti M, Ilut L, Colamonici M, Palivos W, Atsaves PA, Tan D, Kocherginsky M, Weinberg RS, Fish EN, Crispino JD, Hoffman R, Platanias LC. Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms. Nat Commun 2022;13:1750. [PMID: 35365653 DOI: 10.1038/s41467-022-29381-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Yu R, Zhu B, Chen D. Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell Mol Life Sci 2022;79:191. [PMID: 35292881 DOI: 10.1007/s00018-022-04219-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Liu H, Liu S, Song X, Jiang A, Zou Y, Deng Y, Yue C, Li Z, Yang D, Yang C, Sun D, Yang F, Li M, Jiang K, Lu H, Hu W, Zheng Y. Nanoparticle encapsulated CQ/TAM combination harmonizes with MSCs in arresting progression of severity in AP mice through iNOS (IDO) signaling. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100226] [Reference Citation Analysis]
8 Marzio A, Kurz E, Sahni JM, Di Feo G, Puccini J, Jiang S, Hirsch CA, Arbini AA, Wu WL, Pass HI, Bar-sagi D, Papagiannakopoulos T, Pagano M. EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion. Cell 2021. [DOI: 10.1016/j.cell.2021.12.005] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
9 Huang D, Yan W, Han M, Yuan W, Wang P, Chen Y, Wan X, Luo X, Wu D, Ning Q. Insufficient immunity led to virologic breakthrough in NAs-treated chronic hepatitis B patients switching to Peg-IFN-ɑ. Antiviral Res 2021;197:105220. [PMID: 34848218 DOI: 10.1016/j.antiviral.2021.105220] [Reference Citation Analysis]
10 Small S, Numan Y, Platanias LC. Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies. Biomedicines 2021;9:1631. [PMID: 34829860 DOI: 10.3390/biomedicines9111631] [Reference Citation Analysis]
11 Kuiken HJ, Dhakal S, Selfors LM, Friend CM, Zhang T, Callari M, Schackmann RCJ, Gray GK, Crowdis J, Bhang HC, Baslan T, Stegmeier F, Gygi SP, Caldas C, Brugge JS. Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts. Oncogene 2021. [PMID: 34703030 DOI: 10.1038/s41388-021-02075-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Musella M, Galassi C, Manduca N, Sistigu A. The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation. Biology (Basel) 2021;10:856. [PMID: 34571733 DOI: 10.3390/biology10090856] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Wei G, Wang L, Wan X, Tan Y. [ELF4 promotes proliferation and inhibits apoptosis of human insulinoma cells by activating Akt signaling]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1329-33. [PMID: 34658346 DOI: 10.12122/j.issn.1673-4254.2021.09.06] [Reference Citation Analysis]
14 Li Y, Gong L, Qin N, Wei X, Miao L, Yuan H, Wang C, Ma H. Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in oral squamous cell carcinoma. Oral Oncol 2021;121:105437. [PMID: 34265729 DOI: 10.1016/j.oraloncology.2021.105437] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Fenton SE, Saleiro D, Platanias LC. Type I and II Interferons in the Anti-Tumor Immune Response. Cancers (Basel) 2021;13:1037. [PMID: 33801234 DOI: 10.3390/cancers13051037] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
16 Mazewski C, Perez RE, Fish EN, Platanias LC. Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways. Front Immunol 2020;11:606456. [PMID: 33329603 DOI: 10.3389/fimmu.2020.606456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]